Literature DB >> 32926885

Biotin-decorated all-HPMA polymeric micelles for paclitaxel delivery.

Yan Wang1, Mies J van Steenbergen2, Nataliia Beztsinna3, Yang Shi4, Twan Lammers5, Cornelus F van Nostrum6, Wim E Hennink7.   

Abstract

To avoid poly(ethylene glycol)-related issues of nanomedicines such as accelerated blood clearance, fully N-2-hydroxypropyl methacrylamide (HPMAm)-based polymeric micelles decorated with biotin for drug delivery were designed. To this end, a biotin-functionalized chain transfer agent (CTA), 4-cyano-4-[(dodecylsulfanylthiocarbonyl)-sulfanyl]pentanoic acid (biotin-CDTPA), was synthesized for reversible addition-fragmentation chain-transfer (RAFT) polymerization. Amphiphilic poly(N-2-hydroxypropyl methacrylamide)-block-poly(N-2-benzoyloxypropyl methacrylamide) (p(HPMAm)-b-p(HPMAm-Bz)) with molecular weights ranging from 8 to 24 kDa were synthesized using CDTPA or biotin-CDTPA as CTA and 2,2'-azobis(2-methylpropionitrile) as initiator. The copolymers self-assembled in aqueous media into micelles with sizes of 40-90 nm which positively correlated to the chain length of the hydrophobic block in the polymers, whereas the critical micelle concentrations decreased with increasing hydrophobic block length. The polymer with a molecular weight of 22.1 kDa was used to prepare paclitaxel-loaded micelles which had sizes between 61 and 70 nm, and a maximum loading capacity of around 10 wt%. A549 lung cancer cells overexpressing the biotin receptor, internalized the biotin-decorated micelles more efficiently than non-targeted micelles, while very low internalization of both types of micelles by HEK293 human embryonic kidney cells lacking the biotin receptor was observed. As a consequence, the paclitaxel-loaded micelles with biotin decoration exhibited stronger cytotoxicity in A549 cells than non-targeted micelles. Overall, a synthetic pathway to obtain actively targeted poly(ethylene glycol)-free micelles fully based on a poly(HPMAm) backbone was established. These polymeric micelles are promising systems for the delivery of hydrophobic anticancer drugs.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biotin; Drug targeting; N-2-Hydroxypropyl methacrylamide; Nanomedicines; Polymeric micelles

Year:  2020        PMID: 32926885     DOI: 10.1016/j.jconrel.2020.09.013

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

1.  Targeted delivery of capecitabine to colon cancer cells using nano polymeric micelles based on beta cyclodextrin.

Authors:  Hossein Ameli; Nina Alizadeh
Journal:  RSC Adv       Date:  2022-02-08       Impact factor: 3.361

Review 2.  Effects of polymer carriers on the occurrence and development of autophagy in drug delivery.

Authors:  Changduo Wang; Yang Li; Yu Tian; Wenyuan Ma; Yong Sun
Journal:  Nanoscale Adv       Date:  2022-07-20

3.  Biomanufacturing Biotinylated Magnetic Nanomaterial via Construction and Fermentation of Genetically Engineered Magnetotactic Bacteria.

Authors:  Junjie Xu; Shijiao Ma; Haolan Zheng; Bo Pang; Shuli Li; Feng Li; Lin Feng; Jiesheng Tian
Journal:  Bioengineering (Basel)       Date:  2022-07-30

Review 4.  Drug-loaded PEG-PLGA nanoparticles for cancer treatment.

Authors:  Dan Zhang; Lin Liu; Jian Wang; Hong Zhang; Zhuo Zhang; Gang Xing; Xuan Wang; Minghua Liu
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

5.  Paclitaxel-Loaded Magnetic Nanoparticles Based on Biotinylated N-Palmitoyl Chitosan: Synthesis, Characterization and Preliminary In Vitro Studies.

Authors:  Vlad Constantin Ursachi; Gianina Dodi; Alina Gabriela Rusu; Cosmin Teodor Mihai; Liliana Verestiuc; Vera Balan
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

Review 6.  Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery.

Authors:  Magdalena Jurczyk; Katarzyna Jelonek; Monika Musiał-Kulik; Artur Beberok; Dorota Wrześniok; Janusz Kasperczyk
Journal:  Pharmaceutics       Date:  2021-03-03       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.